Pfizer India announces 12-week paternity leave policy for its workforce
The paternity leave policy offers birthing and non-birthing fathers the flexibility to avail leaves over a period of two years.
Advertisement
Mumbai: Pfizer India has announced a 12-week paternity leave policy for its employees as part of its diversity & inclusion initiatives, further bolstering its employee-centric work environment.
The new leave policy is applicable from 1 st January 2023 and can be availed by biological as well as adoptive fathers. The initiative by Pfizer is a significant move towards fostering inclusion, diversity, and equity within the organisation.
The paternity leave policy offers birthing and non-birthing fathers the flexibility to avail leaves over a period of two years. The minimum number of leaves that can be availed in a single tranche is two weeks and the maximum is six weeks. In case of any complexity, the employee will be allowed to take additional leaves under Pfizer’s generous leave policies which include casual leave, elective holiday, and wellness days.
Sharing her views on the new paternity policy, Shilpi Singh, Director People Experience, Pfizer India said, “At Pfizer, people are at the centre of everything we do. We believe the future of a progressive workspace will be defined by practices that harness a people-first approach. The 12-week paternity leave policy will most certainly enable our male colleagues and their partners to cherish the experience and joyful moments of parenthood. A progressive policy of this nature is our endeavor to harness the power of Equity at the workplace and enable both men and women to invest equal time in essaying their roles and responsibilities as a parent.”
Some other employee benefits offered by the company are Telemedicine with access to doctors across 30+ therapeutic specialties, EAP (Employee Assistance Program) that offers global wellness and mental health support, medical plan, and infertility treatment up to maximum of maternity coverage.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.